The legal cannabis testing sector is plagued by lab shopping. Is there a solution in sight? Analytical Cannabis looks at six possible reactions to this growing issue.
Sherman Hom of Medicinal Genomics unpacks the company's new compendium of US state cannabis testing requirements.
Analytical Cannabis caught up with Harold Han, founder and chief science officer at the Oakland-based infusion technology company Vertosa, to hear the latest developments from the world of cannabis emulsion research.
To learn more about what CBD regulations and the market looks like now in 2023, Analytical Cannabis spoke to Dr. Parveen Bhatarah, the regulatory and compliance associate at the ACI.
Analytical Cannabis recently spoke with Ananda’s Head of Plant Science, Dr. Nigel Gale, to learn more about this research and the advantages that a seed-based cultivation strategy could have for cultivators.
In the second of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
The legal status of cannabis in the UK is in a state of flux, becoming more relaxed in various ways, but too slowly for some. John Binns, a cannabis specialist at BCL Solicitors LLP, gets into the weeds.
In the first of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
Eric Schneider, the managing director of AlphaRoot, a tech-enabled cannabis insurance broker, explains how cannabis cultivators can maintain their momentum in the industry.